ARCHIVES

“Sloppy” Cancer Control Grant Applications Turned Down At Twice NIH Disapproval Rate

This article is from The Cancer Letter archive.

Vol. 01 No. 45 | November 7, 1975

Download PDF Visit The Full Archive

Related Articles

Cancer Advocates Use Benefit Analysis To Press For Funds

May 11, 1990

NIH Considering Intramural NRSA, NCI Advisors Not Enthusiastic

February 17, 1984

FDA Oncology Division Invites Advocates To Play Early Role In Cancer Drug Review.

March 23, 2001

GAO Investigation Of Cancer Control Focuses On Five Contracts, Finds Alleged Deficiencies

July 18, 1980

Also in this 8-page issue: David Hohn elected board chairman of the National Comprehensive Cancer Network.

March 26, 2004

Cancer Survivorship: NCI, Komen, OWH Fund Research Grants

December 5, 1997